Greek asthma patients tracked for 2 years on new biologic drug
NCT ID NCT06724575
Summary
This study is observing 155 adults with severe, uncontrolled asthma in Greece who are newly prescribed the biologic drug tezepelumab. The goal is to see how well the drug controls asthma symptoms and improves quality of life over two years in a real-world clinic setting, outside of a controlled trial. Researchers will track symptom scores, lung function, and steroid use to understand the long-term benefits of this treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Alexandroupoli, Greece
-
Research Site
Athens, Greece
-
Research Site
Corfu, Greece
-
Research Site
Crete, Greece
-
Research Site
Ioannina, Greece
-
Research Site
Larissa, Greece
-
Research Site
Pátrai, Greece
-
Research Site
Thessaloniki, Greece
Conditions
Explore the condition pages connected to this study.